NCT06795113View on ClinicalTrials.gov

Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma

RecruitingOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

June 1, 2013

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Lymphoma
Trial Locations (1)

Unknown

RECRUITING

Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai

All Listed Sponsors
collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

West China Hospital

OTHER

lead

Ruijin Hospital

OTHER